1204 PHARMACOKINETICS OF MIRAVIRSEN, A MIR-122 INHIBITOR, PREDICT THE PROLONGED VIRAL LOAD REDUCTION IN TREATMENT NAIVE GENOTYPE 1 HCV INFECTED PATIENTS
Authors:
- R. PerssonRPR. Persson
- M. HodgesMHM. Hodges
- B.D. KingBKB.D. King
- A. ChenACA. Chen
- K. ZehKZK. Zeh
- A.A. LevineALA.A. Levine
- 30 April 2012
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 56, S477